All In Biotech

Drug Trial Radar · NCT06625411

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

REVEAL-1 - A Phase 3, Randomized, Double-masked, Placebo-controlled, Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Last checked: Nov 20, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

132

Actual

Start

Aug 27, 2024

Primary completion

Feb 12, 2026

Study completion Nov 15, 2026

Sponsor

Lead sponsor
Viridian Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, VRDN-003, in participants with active Thyroid Eye Disease (TED).

Conditions

  • Thyroid Eye Disease

Interventions

  • VRDN-003Drug

    VRDN-003 is an investigational, subcutaneously administered, humanized monoclonal antibody directed against the Insulin-like Growth Factor-1 receptor (IGF-1R).

  • PlaceboDrug

    All participants will receive the same number of injections to maintain masking. Masking will be maintained by the use of placebo injections that appear identical to VRDN-003 injections.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proptosis Responder Rate in the most proptotic eye as measured by exophtalmometerTime frame: At Week 24

Locations

48 sites in 5 countries. Site status is shown where the registry gives one.

  • Scottsdale Clinical Trials

    Scottsdale, Arizona

  • Alliance Research Institute - Canoga Park

    Canoga Park, California

  • Marvel Clinical Research

    Huntington Beach, California

  • United Medical Research Institute

    Inglewood, California

  • Advancing Research International, LLC

    Los Angeles, California

  • Roski Eye Institute, Keck School of Medicine, USC

    Los Angeles, California

  • Alliance Research Institute - Lynwood

    Lynwood, California

  • A.P.J. Office

    Newport Beach, California

  • Byers Eye Institute at Stanford University

    Palo Alto, California

  • Pasadena Clinical Trials

    Pasadena, California

  • Cockerham Eye Consultants, PC

    San Diego, California

  • C&A Clinical Trials Corp

    Cape Coral, Florida

  • Ilumina Medical Research

    Kissimmee, Florida

  • Med-Care Research

    Miami, Florida

  • Continental Clinical Research

    Miami, Florida

  • Hype Clinical Research LLC

    Miami, Florida

  • Anmed Health Services LLC

    Miami, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Agile Clinical Research Trials, LLC

    Atlanta, Georgia

  • Vision Medical Research

    Orland Park, Illinois

  • Opthalmic Consultants of Boston

    East Weymouth, Massachusetts

  • Fraser Eye Care Center

    Fraser, Michigan

  • Kahana Oculoplastic & Orbital Surgery

    Livonia, Michigan

  • University Health

    Kansas City, Missouri

  • S.L. Office

    Las Vegas, Nevada

  • Vector Clinical Trials

    Sparks, Nevada

  • Rutgers New Jersey Medical School

    Newark, New Jersey

  • Asheville Clinical Research

    Asheville, North Carolina

  • Duke Eye Center

    Durham, North Carolina

  • Baylor College of Medicine/Alkek Eye Center

    Houston, Texas

  • Gulf Coast Clinical Trials

    Houston, Texas

  • Neuro-Eye Clinical Trials

    Houston, Texas

  • University of Washington, Eye institute

    Seattle, Washington

  • West Virginia University Eye Institute

    Morgantown, West Virginia

  • Charité Universitätsmedizin Berlin KöR

    Berlin, Germany

  • Universitätsklinikum Carl- Gustav- Carus- Dresden

    Dresden, Germany

  • Klinikapotheke des Universitätsklinikums Gießen und Marburg GmbH (UKGM)

    Giessen, Germany

  • Universitaetsmedizin Goettingen

    Göttingen, Germany

  • Budapest Retina Intezet

    Budapest, Hungary

  • Pecsi Tudomanyegyetem Klinikai Kozpont, Szemeszeti Klinika

    Pécs, Hungary

Showing 40 of 48 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.